Figure 4.
In the Chronic Renal Insufficiency Cohort, eventfree survival with combination treatment versus placebo treatment for (A) doubling of serum creatinine/kidney failure/death and (B) doubling of serum creatinine/kidney failure.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.